Sellas Life Sciences

Press Release: Potential Treatment for Parkinson’s & Parkinson-Like Diseases with Zolpidem: SELLAS LIFE SCIENCES GROUP HOLDS GLOBAL DEVELOPMENT & MARKETING RIGHTS

Zurich, Switzerland – Athens, Greece – December 10, 2013  SELLAS LIFE SCIENCES GROUP takes Zolpidem into Phase II clinical studies for the treatment of Parkinson’s Disease (PD) and Progressive Supranuclear Palsy (PSP) Clinical studies will initially take place in Europe and,...
Read More →